0.00% +0.010

NeuroPace Inc (NPCE)

NeuroPace Inc Aktie (NPCE) Neueste Nachrichten

NeuroPace Inc (NPCE)

NeuroPace Inc Aktie (NPCE) Neueste Nachrichten

Further Upside For NeuroPace, Inc. (NASDAQ:NPCE) Shares Could Introduce Price Risks After 39% Bounce - Yahoo New Zealand News

Brain Computer Interfaces in Medicine Market Business Insights, Key Trend Analysis | NeuroPace Inc, Mindmaze SA, G ... - Amoré

NeuroPace, Inc. (NASDAQ:NPCE) Sees Significant Decrease in Short Interest - MarketBeat

Objective long/short (NPCE) Report - Stock Traders Daily

NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

NeuroPace (NASDAQ:NPCE) vs. Accuray (NASDAQ:ARAY) Financial Contrast - Defense World

Wells Fargo maintains Overweight on NeuroPace with $20 target - Investing.com India

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com Australia

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference - The Globe and Mail

Market Watch Highlights: NeuroPace Inc (NPCE) Ends on an Downturn Note at 7.53 – DWinneX - The Dwinnex

NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions - Yahoo Finance UK

Trend Tracker for (NPCE) - Stock Traders Daily

Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News

Contrasting Tactile Systems Technology (NASDAQ:TCMD) and NeuroPace (NASDAQ:NPCE) - Defense World

NeuroPace (NPCE) Price Target Increased by 17.52% to 9.35 - MSN

NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still ... - Yahoo Movies UK

NeuroPace to Participate in Two Healthcare Conferences in May - Investing.com India

Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat

Brain Computer Interface Technology Market 2024 Trends with Analysis on Key Players NeuroPace Inc, Emotiv Inc ... - Amoré

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

NeuroPace's (NPCE) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World

Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat

Q2 2024 EPS Estimates for NeuroPace, Inc. Decreased by Analyst (NASDAQ:NPCE) - Defense World

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion By Investing.com - Investing.com Canada

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion - Investing.com India

FY2028 Earnings Estimate for NeuroPace, Inc. Issued By Leerink Partnrs (NASDAQ:NPCE) - Defense World

NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript - Seeking Alpha

Have Insiders Been Buying NeuroPace, Inc. (NASDAQ:NPCE) Shares? - Yahoo Lifestyle UK

NeuroPace, Inc. to Post FY2028 Earnings of $0.27 Per Share, Leerink Partnrs Forecasts (NASDAQ:NPCE) - MarketBeat

NeuroPace First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Brain Computer Interfaces in Medicine Market 2031 Key Insights and Leading Players NeuroPace, Inc, Mindmaze - Motions Online

NeuroPace First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Neuropace's Financial Health: Navigating Risks Tied to RNS System Dominance and Supplier Dependencies ... - TipRanks

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

NeuroPace (NASDAQ:NPCE) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update - 08.05.2024 - wallstreet:online

Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates

Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News

NeuroPace (NPCE) Set to Announce Quarterly Earnings on Wednesday - Defense World

Orbimed Advisors Llc Sells 4,674 Shares of NeuroPace, Inc. (NASDAQ:NPCE) Stock - MarketBeat

Brain Computer Interfaces in Medicine Market 2024 [Key Trends] | NeuroPace Inc, Mindmaze SA, G.TEC - Motions Online

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 - Investing.com India

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

Ähnlich wie NPCE